Convergence Investment Partners, LLC Merck & Co., Inc. Transaction History
Convergence Investment Partners, LLC
- $261 Million
- Q1 2024
A detailed history of Convergence Investment Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 22,977 shares of MRK stock, worth $2.91 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
22,977
Previous 19,562
17.46%
Holding current value
$2.91 Million
Previous $2.13 Million
42.15%
% of portfolio
1.16%
Previous 1.11%
Shares
27 transactions
Others Institutions Holding MRK
# of Institutions
3,769Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.8 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.2 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.13 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $320B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...